Madrigal registers two resmetirom studies: Phase 1b in MASH/HFpEF and Phase 4 drug-interaction trialOct 16Weekly roundup, 2 itemsMadrigal Pharmaceuticals, Inc.resmetirom
Madrigal registers Phase 4 safety study of Rezdiffra with diabetes drugs in MASH patientsSep 29Trial updateMadrigal Pharmaceuticals, Inc.resmetirom